Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid

Tiffany Enxia Jiang, Reshma Ramachandran, Kerstin N. Vokinger, Joseph S. Ross

Open source

DOI
10.1080/20523211.2025.2564405
Published
2025-10
Container
Journal of Pharmaceutical Policy and Practice
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20523211.2025.2564405,
  title = {Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid},
  author = {Tiffany Enxia Jiang and Reshma Ramachandran and Kerstin N. Vokinger and Joseph S. Ross},
  year = {2025},
  journal = {Journal of Pharmaceutical Policy and Practice},
  doi = {10.1080/20523211.2025.2564405},
  url = {https://doi.org/10.1080/20523211.2025.2564405}
}

RIS

TY  - JOUR
TI  - Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid
AU  - Tiffany Enxia Jiang
AU  - Reshma Ramachandran
AU  - Kerstin N. Vokinger
AU  - Joseph S. Ross
PY  - 2025
JO  - Journal of Pharmaceutical Policy and Practice
DO  - 10.1080/20523211.2025.2564405
UR  - https://doi.org/10.1080/20523211.2025.2564405
ER  - 

APA

Jiang, T. E., Ramachandran, R., Vokinger, K. N., & Ross, J. S. (2025). Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid. Journal of Pharmaceutical Policy and Practice. https://doi.org/10.1080/20523211.2025.2564405

Source records